The current valuation score of CervoMed Inc is 6.43, ranking 324 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.12, which is -1356.83% below the recent high of 14.14 and -2724.66% above the recent low of -31.77.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.